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Clinical Scenario 
Exercise-associated muscle damage results in elevated plasma creatine kinase (CK), often 
diagnosed as exertional rhabdomyolysis (ER) in runners.  Likewise, exercise-associated 
hyponatremia (EAH) is prevalent in ultra-endurance racers.  A link has been proposed between 
ER and EAH in that the simultaneous presentation of EAH and ER creates a complicated and 
opposing treatment paradox regarding fluid resuscitation. 
 
Focused Clinical Question 
What is the relationship between EAH and ER in ultra-endurance athletes? 
 
Search Strategy 
 The database searched was Pub Med  
 The following keywords were used: creatine kinase, athletes, muscle damage, exercise-
induced muscle damage and rhabdomyolysis 
 The criteria for study selection were:  human subjects, peer-reviewed, English language, 
published within last 2 years 
 Critical appraisal was conducted according to the Oxford Center for Evidence-Based 
Medicine (OCEBM) and the Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE) statement. 
 
Study Selected 
 Chlibkova D, Knechtle B, Rosemann T, et al. Rhabdomyolysis and exercise-associated 
hyponatremia in ultra-bikers and ultra-runners.  J Int Soc Sports Nutr. 2015;12:29.   
DOI 10.1186/s12970-015-0091-x.  Published online June 25, 2015. 
 
Evidence Quality Assessment 
This investigation utilized a multiple-group, non-randomized, cohort-control research design, or 
a Level 2b according OCEBM.  The STROBE statement was used to assess the quality of this 
study, which met 19/22 of the criteria. 
 
Study Patients and Sampling.  Subjects were 113 ultra-endurance athletes participating in a 
variety of ultra-events (ultra-mountain bikers: stage racers and 24-hr ultra-bikers; ultra-runners: 
24-hr ultra- and 100-km ultra-runners).  The study included 6 race finishers with rhabdomyolysis 
as diagnosed by blood CK levels >10,000 U/L without the development of renal failure or 
necessity of medical treatment. 
 
Control Group.  The control group consisted of 100 normonatremic ultra-athletes who 
completed their respective event and provided a complete data set of blood and urine samples.  
Of the normonatremic finishers, 4 (4 %) ultra-runners (all men) developed ER.  
 
Experimental Group.  The researchers found 13 hyponatremic athletes diagnosed with post-
race plasma [Na+] <135 mmol/L with 2 (15.4 %, one man and one woman) who developed ER. 
 
Outcome Measures.  Athletes agreed to provide blood and urine measurements during 
registration the day before each race and upon completion of the race.  Blood samples were 
analyzed for plasma [Na+], [K+], CK, and urine creatinine; only CK and [Na+] are reported here. 
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Clinical Bottom Line(s) 
1. Of the ultra-endurance race finishers in this study (n=113), 5.3% developed ER with CK 
>10,000 U/L and 15.9 % developed ER/myopathy (CK >2,000 U/L).  Of the ultra-runners, 
28.6% (6/21) developed ER and none of the ultra-mountain bikers.  Hyponatremic ultra-
athletes developed ER more often than normonatremic ultra-athletes.   
2. Due to the wide inter-individual ranges of CK and the excessively high CK in asymptomatic 
ultra-athletes, the value of CK as a prognostic or diagnostic tool is questionable. 
3. In situations where the diagnosis of EAH is uncertain, treatment with fluid restriction is 
contraindicated in case of dehydration and ER which may lead to acute kidney injury. 
 
Implications for Practice, Education, and Future Research 
The overall incidence rate of ER was 5.3% (6/113) in ultra-endurance race finishers and 28.6% 
(6/21) of ultra-runners.  Ultra-athletes who developed ER had an average post-race CK= 
18,423.6±6,138.8 U/L (range= 12,786.2-29,702.9 U/L).  These ranges for post-race CK far 
exceed the 5-10 times upper limit of normal for CK for diagnosis of ER, indeed these athletes 
had 9,659.0±8,793.3% (2,665.0±26,209.0%) increased CK from baseline.  Further, the ultra-
runners who did not present with ER also reported with exceedingly high CK, but were 
asymptomatic.  The table below was calculated in aggregate from the data provided by the 
researchers and includes the plasma [Na+] and CK averages, ranges, and % change from 
baseline for all ultra-race finishers.  In the EAH and ER group, post-race CK increased 
7,160.3±6,238.4% (2,749.0±11,571.5%) from pre-race while in the ER only group post-race CK 
increased 10,908.4±10,471% (2,665.0-26,209.0) from pre-race.  In all the ultra-runners (n=21) 
CK increased 3,365.8±4,098.7% (990.7-5,782.1%) from pre-race while in all the mountain 
bikers (n=82) CK increased 458.9±511.3% (308.1-590.9%) from pre-race.  The total finished 
ultra-marathons, total hours spent training weekly, and gender were related to post-race CK 
concentration (P >0.05) in both groups.   
 
Comments:  The major strengths of this investigation were external validity or the 
generalizability of the sample of the large variety of ultra-endurance events and the number and 
quality of the variables assessed.  Fortunately, none of the ultra-runners who developed ER 
required medical intervention.  The major limitation of this investigation was the small sample 
size for the athletes who developed ER, as expected with the low incidence rate of this condition 
in well-trained athletes.  Furthermore, the investigators did not confirm the presence of 
myoglobinuria, although this clinical indicator is less sensitive and not clinically useful.  Finally, 
following the subjects for an additional 24-72 hr would have likely demonstrated increased CK, a 
reliable clinical indicator of more severe rhabdomyolysis. 
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Table.  Post-race plasma sodium [Na+] and creatine kinase (CK) in ultra-endurance athletes 
Event 
(gender)  
Pre-Race [Na+] 
(mmol/L) 
Post-Race [Na+] 
(mmol/L) 
%change from 
Pre-Race 
Pre-Race CK 
(mmol/L) 
Post-Race CK 
(mmol/L) 
%change from 
Pre-Race 
Athletes* with 
EAH  
M±SD 137.5±0.7 133.5±0.7 -2.9±0.0 319.7±268.3 14,842.9±466.7 7,160.3±6,238.4 
and ER  
(n=2, all men) 
Range 137.0-138.0 133.0-134.0 -2.9 130.0-509.4 14,512.9±15,172.9 2,749.0±11,571.5 
Athletes* with 
ER 
M±SD 139.0±1.8 138.0±2.4 -0.7±3.0 309.9±246.8 20,213.9±7,065.0 10,908.4±10,471.5 
(n=4, 2 men,  
2 women) 
Range 137.0-141.0 135.0-141.0 -4.3 to 2.9 112.9-654.1 12,786.2-29,702.9 2,665.0-26,209.0 
Ultra-Mountain 
Bikers 
M±SD 140.0±2.1 138.1±2.3 -1.3±1.9 164.0±72.3 828.2±657.8 458.9±511.3 
(n=82, 66 men,  
16 women) 
Range 137.5-142.8 136.6-140.0 -1.9 to -0.6 118.9-207.5 418.1-1,316.3 308.1-590.9 
Ultra-Runners  M±SD 139.5±2.1 137.7±2.5 -0.6±2.2 200.3±138.0 5,156.8±6,079.2 3,365.8±4,098.7 
(n=21, 12 men,  
9 women) 
Range 138.4-140.1 136.0-139.1 -1.7 to 1.3 99.0-251.1 1,949.3-8,813.8 990.7-5,782.1 
Note.  EAH= exercise-associated hyponatremia, ER= Exertional rhabdomyolysis 
*All athletes who developed ER were ultra-runners 
 
